Asian shares on firm footing as vaccine trials resume

Daniel Fowler
September 20, 2020

Oxford University, AstraZeneca's partner on the vaccine, has already resumed its trial in Britain.

A total of 50,000 people are due to participate globally in the trials.

AstraZeneca and the University of Oxford have not disclosed any medical information on the nature of the illness.

"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume".

The illness that triggered the global pause, which occurred in a woman who was in the vaccine arm of the United Kingdom trial, has not been officially disclosed, though AstraZeneca CEO Pascal Soriot told a group of investors on Wednesday that her symptoms were consistent with transverse myelitis, a serious condition involving inflammation of the spinal cord that can cause muscle weakness, paralysis, pain and bladder problems, American health-oriented news website Stat News reported.

The status of the South African and Indian trials remains unknown, but the trial in Brazil has also restarted.

On Tuesday the vaccination of 150 volunteer participants in the phase 2 clinical trial of the first vaccine against Covid-19 to be trialled in Spain, made by pharmaceutical company Janssen, began in Madrid.

China's COVID-19 inactivated vaccines available by 2020 end
Furthermore, Prasad said that the signs are good and their aim is to get the vaccine in the shortest period of time. According to Murashko, symptoms after being injected with the anti-coronavirus vaccine "level off" by the next day.

The AZD1222 project is one of the most promising of the potential vaccines in development and one of the furthest along the safety and efficacy testing programme. And that's precisely what's happening with the AstraZeneca vaccine trial.

Dr. Nawal Al-Kaabi said that the UAE hosts a number of advanced clinical trial facilities, such as the ADNEC Center, which is considered one of the world's largest field clinics for trials, supporting the participation of 31,000 volunteers from 125 nationalities.

It is an early phase of the research, in which it is meant to evaluate which is the most appropriate dose and schedule in terms of activity to achieve the best antibody response (those that generate immunity against the virus), as well as to continue evaluating safety of the product under investigation.

"The complications are described in the instructions and are predictable", he said.

Many countries are vying for the coronavirus vaccine. The company started its trial on the same day as Pfizer, said on September 4.

"So it is critical we explore whether targetting the airways directly can provide an effective response compared to a vaccine injected into muscle".

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER